Table 1.
Study | References | Country | Case definition (numbers in trial) | Median day of commencing KMC | Outcome | Design/ limitations |
---|---|---|---|---|---|---|
1 | Charpak et al.,8 1997a | Colombia (facility) | Neonates <2000 g (n = 746) | 4 days | Mortality at 12 months but provided neonatal specific data | RCT—outcome assess not blinded |
2 | Suman et al.,15 2008 | India (facility) | Neonates <2000 g (n = 206) | 3.7 days | Mortality at 9 months but provided neonatal specific data | RCT—outcome assess not blinded |
3 | Worku et al.,16 2005 | Ethiopia (facility) | Neonates <2000 g (n = 123) | 10 h | Neonatal mortality | RCT—poor description of R and follow up |
X | Sloan et al.,14 2008 | Bangladesh (community) | All neonates (n = 4165) (<2000 g = 166 and analysis restricted to <2000 g) | 4 h | Neonatal mortality | Cluster RCT, more erratic implementation of KMC. Birthweight data missing for 65%. Possible undercounting of deaths |
X | Sloan et al.,17 1994a | Ecuador (facility) | Neonates <2000 g (n = 300) | 12.4 days | Mortality at 6 months | RCT—outcome assess not blinded |
X | Cattaneo et al.,18 1998a | Mexico, Indonesia, Ethiopia (facility) | Neonates 1000–1999 g (n = 285) | 10 days | Pre-discharge mortality | RCT—outcome assess not blinded |
X indicates not included in this analysis because intervention (KMC) only commenced after the first week of life and >75% of deaths in very low birth weight babies occur during this time. See text for details and sensitivity analysis.
aIncluded in Cochrane 2003, Conde-Agudelo A et al.11